AVIS BUDGET GROUP, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AVIS BUDGET GROUP, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.65B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $11.79B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $12.01B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $11.99B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $9.31B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $5.40B | Feb 16, 2023 |
| FY2019 | Dec 31, 2019 | $2.16B | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | $2.75B | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | $2.34B | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | $1.92B | Feb 20, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $2.02B | Feb 22, 2018 |
| FY2017 | Sep 30, 2017 | $2.75B | Feb 22, 2018 |
| FY2017 | Jun 30, 2017 | $2.24B | Feb 22, 2018 |
| FY2017 | Mar 31, 2017 | $1.84B | Feb 22, 2018 |
| FY2017 | Dec 31, 2016 | $1.88B | Feb 22, 2018 |
| FY2017 | Sep 30, 2016 | $2.66B | Feb 22, 2018 |
| FY2017 | Jun 30, 2016 | $2.24B | Feb 22, 2018 |
| FY2017 | Mar 31, 2016 | $1.88B | Feb 22, 2018 |
| FY2016 | Dec 31, 2015 | $1.90B | Feb 21, 2017 |
| FY2016 | Sep 30, 2015 | $2.58B | Feb 21, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($889.00M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($1.82B) | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.63B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $2.76B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $1.29B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | ($684.00M) | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $302.00M | Feb 17, 2022 |
| FY2018 | Dec 31, 2018 | $13.00M | Feb 21, 2019 |
| FY2018 | Sep 30, 2018 | $213.00M | Feb 21, 2019 |
| FY2018 | Jun 30, 2018 | $26.00M | Feb 21, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.45B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.35B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.41B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $1.35B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $1.15B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $703.00M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $1.24B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $1.22B | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $1.12B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $1.13B | Feb 21, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.30B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $3.52B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $3.83B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $4.71B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $3.49B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $691.00M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $2.59B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $2.61B | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $2.65B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $2.64B | Feb 21, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.26B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $29.04B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $32.57B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $25.93B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $22.60B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $17.54B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $23.13B | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $19.15B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $17.70B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $17.64B | Feb 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.13B) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($2.33B) | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | ($349.00M) | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | ($703.00M) | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | ($220.00M) | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | ($155.00M) | Feb 17, 2022 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.13B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.07B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.10B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $1.07B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $1.11B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $1.14B | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $1.10B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $1.09B | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $1.07B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $1.01B | Feb 21, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.14B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $2.03B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $3.85B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $2.58B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | ($185.00M) | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | ($1.47B) | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | ($785.00M) | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | ($1.09B) | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | ($1.22B) | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | ($1.64B) | Feb 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $519.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $534.00M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $555.00M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $570.00M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $534.00M | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $692.00M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $686.00M | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $615.00M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $611.00M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $490.00M | Feb 22, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $4.01B | Feb 17, 2022 |
| FY2021 | Dec 31, 2020 | $4.21B | Feb 17, 2022 |
| FY2014 | Dec 31, 2014 | $3.39B | Feb 23, 2015 |
| FY2014 | Dec 31, 2013 | $3.36B | Feb 23, 2015 |
| FY2013 | Dec 31, 2012 | $2.84B | Feb 21, 2014 |
| FY2012 | Dec 31, 2011 | $3.17B | Feb 21, 2013 |
| FY2011 | Dec 31, 2010 | $2.50B | Feb 29, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (25) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | (51) | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 42 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 58 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 19 | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | (9) | Feb 16, 2023 |
| FY2019 | Dec 31, 2019 | 1 | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | 2 | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | (1) | Feb 20, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (25) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | (51) | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 42 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 57 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 19 | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | (9) | Feb 16, 2023 |
| FY2019 | Dec 31, 2019 | 1 | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | 2 | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | (1) | Feb 20, 2020 |